LUNGevity Foundation Joins 2025 LungXperience Tour to Promote Lung Health and Early Detection Across the U.S.

Organization to Participate in 12 National Events as Part of Innovative Health Education Initiative

WASHINGTON, July 24, 2025 /PRNewswire/ -- LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit, is proud to announce its participation in the 2025 LungXperience Tour, a national mobile health initiative created in partnership with AstraZeneca and Kroger Health. As part of the tour, LUNGevity will be onsite at 12 major events across the country to raise awareness about the importance of lung health and the life-saving benefits of lung cancer screening.

At the heart of the program is the LungXperience exhibit, a striking 20'x20' inflatable lung that invites visitors to walk through and explore the inner workings of the lungs. This powerful educational experience helps attendees understand lung anatomy, learn about risk factors for diseases like lung cancer and COPD, and discover how screening can save lives.

"We're proud to partner with LUNGevity Foundation to bring vital lung cancer awareness and risk education into communities," said Arun Krishna, Vice President and Head of US Oncology for Lung Cancer at AstraZeneca. "Our team is deeply committed to eliminating lung cancer as a cause of death for every patient at every stage—and we're excited to support the LungXperience as it drives important conversations about lung health across the country."

"Early detection saves lives, and programs like LungXperience are critical to reaching people where they are," said Andrea Ferris, President and CEO of LUNGevity. "We are proud to bring education about the importance of lung cancer screening to communities across the country, especially those that are underserved or may have limited access to healthcare resources." LUNGevity's presence at these events ensures that people not only learn about lung health but also understand the importance of timely lung screening and access resources to take action."

LUNGevity's participation includes providing:

• Educational materials on lung cancer risk, symptoms, and screening
• Information on clinical trials and early detection
• On-site engagement with LUNGevity staff and volunteers
• Access to digital tools and resources through QR codes and giveaways

The 2025 LungXperience tour will make stops at a variety of high-traffic events, including NASCAR races, NHRA events, and state fairs, reaching a projected audience of over one million people. LUNGevity will be present at 12 of these events in the coming months.

Upcoming LUNGevity Appearances on the LungXperience Tour Include:

• Indianapolis Motor Speedway (July 25–27)
• Ohio State Fair (July 31–August 3)
• Richmond International Raceway (August 15–16)
• Tennessee State Fair (August 20 – 23)
• NHRA Indianapolis (August 29–31)
• Chicago Oktoberfest (September 5- 7)
• Kansas State Fair (September 11–14)
• Kroger Health & Wellness Festival in Cincinnati (September 26–27)
• Charlotte Motor Speedway, Kroger Store (October 3)
• Las Vegas Motor Speedway (October 10-12)
• Phoenix Raceway (October 31 – November 2)
• NHRA Finals, Pomona (November 13-16)

To learn more about LUNGevity's participation and the full tour schedule, visit www.LUNGevity.org. 

About LUNGevity Foundation

LUNGevity, the nation's leading lung cancer organization, is transforming what it means to be diagnosed and live with lung cancer. LUNGevity seeks to make an immediate impact on quality of life and survivorship for everyone touched by the disease—while promoting health equity by addressing disparities throughout the care continuum.

• Through research, we use an innovative and holistic approach to finding lung cancer earlier when it is most treatable; advance research into new treatments so people may live longer and better; and ensure a diverse, vital pipeline of investigators for the future of the lung cancer field.
• Through advocacy, we foster groundbreaking collaborations to ensure all people have access to screening, biomarker testing, and treatment breakthroughs.
• Through community, we educate, support, and connect people affected by lung cancer so that they can get the best healthcare and live longer and better lives.

Comprehensive resources include a medically vetted and patient-centric website, Patient Gateways for specific types of lung cancer, a toll-free HELPLine for personalized support, international survivor conferences, and tools to find a clinical trial. All these programs are designed to help us achieve our vision—a world where no one dies of lung cancer. LUNGevity Foundation is proud to be a four-star Charity Navigator organization.

Please visit www.LUNGevity.org to learn more. 

About Lung Cancer in the US

• About 1 in 18 Americans will be diagnosed with lung cancer in their lifetime.
• More than 234,000 people in the US will be diagnosed with lung cancer this year, with a new diagnosis every 2.2 minutes.
• It is estimated that close to 65% of all new lung cancer diagnoses are among people with no tobacco exposure or only past tobacco exposure.
• More lives are lost to lung cancer than to the next two deadliest cancers (colorectal and pancreatic) combined.
• Only 27% of all people diagnosed with lung cancer will survive 5 years or more, but if it's caught before it spreads, the chance of 5-year survival improves to 64%.

SOURCE LUNGevity Foundation